Skip links

Elevidys™ (delandistrogene moxeparvovec-rokl)

Full Name Elevidys™ (delandistrogene moxeparvovec-rokl)
Drug Elevidys
Manufacturer Sarepta Therapeutics, Inc.
Route of Administration Intravenous
Site of Care Healthcare Facility
Approved Indication Treatment of adult patients with symptomatic gene mutation confirmed limb-girdle muscular dystrophy type R5 (LGMDR5)
Disease Limb-Girdle Muscular Dystrophy Type R5 (LGMDR5)
Therapeutic Area Neurology, Genetics
Enrollment Form Link Enrollment Form
Phone Number 800-240-9572
Fax Number 877-220-7581
Product Website